Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies.
作者信息
Chapel H M
机构信息
John Radcliffe Hospital, Oxford.
出版信息
BMJ. 1994 Feb 26;308(6928):581-5. doi: 10.1136/bmj.308.6928.581.
Abstract
摘要
相似文献
1
Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies.原发性抗体缺陷诊断与管理共识。原发性抗体缺陷诊断与管理共识小组。
BMJ. 1994 Feb 26;308(6928):581-5. doi: 10.1136/bmj.308.6928.581.
2
[Immunologic deficiencies. Optimizing diagnostic and therapeutic approaches].
Rev Prat. 2007 Oct 15;57(15):1637-8.
3
[Immunologic deficiencies].
Sem Hop. 1973 May 26;49(25):1845-7.
4
Evaluation of immunity.
Immunol Invest. 1987 Oct;16(6):453-99. doi: 10.3109/08820138709087098.
5
6
Management of primary antibody deficiency with replacement therapy: summary of guidelines.用替代疗法治疗原发性抗体缺陷：指南摘要
Immunol Allergy Clin North Am. 2008 Nov;28(4):875-6, x. doi: 10.1016/j.iac.2008.07.003.
7
Immune deficiency: office evaluation and treatment.免疫缺陷：门诊评估与治疗
Allergy Asthma Proc. 2003 Nov-Dec;24(6):409-15.
8
[Prevention of infections in primary and secondary antibody deficiency].[原发性和继发性抗体缺陷中的感染预防]
Przegl Epidemiol. 2009;63(1):55-60.
9
Antibody deficiency testing for primary immunodeficiency: A practical review for the clinician.原发性免疫缺陷的抗体缺陷检测：临床医生的实用综述。
Ann Allergy Asthma Immunol. 2019 Nov;123(5):444-453. doi: 10.1016/j.anai.2019.08.012. Epub 2019 Aug 23.
10
[Immunopathological bases and clinical considerations on the primary immunological deficiencies].[原发性免疫缺陷的免疫病理学基础与临床考量]
Recenti Prog Med. 1972 Jul;53(1):1-64.
引用本文的文献
1
Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortage.在全球短缺的情况下，原发性免疫缺陷患者标准化皮下免疫球蛋白剂量减少策略的感染结局
Front Immunol. 2025 Jan 20;15:1527514. doi: 10.3389/fimmu.2024.1527514. eCollection 2024.
2
The Role of the Immune Response in the Pathogenesis of Bronchiectasis.免疫应答在支气管扩张发病机制中的作用。
Biomed Res Int. 2018 Mar 18;2018:6802637. doi: 10.1155/2018/6802637. eCollection 2018.
3
Use of subcutaneous immunoglobulin in primary immune deficiencies.皮下注射免疫球蛋白在原发性免疫缺陷病中的应用。
Turk Pediatri Ars. 2016 Mar 1;51(1):8-14. doi: 10.5152/TurkPediatriArs.2016.3058. eCollection 2016 Mar.
4
Experience with Subgam, a Subcutaneously Administered Human Normal Immunoglobulin (ClinicalTrials.gov--NCT02247141).皮下注射用人正常免疫球蛋白Subgam的使用经验（ClinicalTrials.gov——NCT02247141）
PLoS One. 2015 Jul 29;10(7):e0131565. doi: 10.1371/journal.pone.0131565. eCollection 2015.
5
Primary immune deficiencies - principles of care.原发性免疫缺陷——护理原则
Front Immunol. 2014 Dec 15;5:627. doi: 10.3389/fimmu.2014.00627. eCollection 2014.
6
7
Subcutaneous immunoglobulin for primary and secondary immunodeficiencies: an evidence-based review.皮下免疫球蛋白治疗原发性和继发性免疫缺陷：循证综述。
Drugs. 2013 Aug;73(12):1307-19. doi: 10.1007/s40265-013-0094-3.
8
Human normal immunoglobulin in the treatment of primary immunodeficiency diseases.人正常免疫球蛋白在原发性免疫缺陷病治疗中的应用。
Ther Clin Risk Manag. 2012;8:157-67. doi: 10.2147/TCRM.S22599. Epub 2012 Apr 2.
9
Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.原发性免疫缺陷病（PI）的全球研究--诊断、治疗和经济影响：杰弗里·莫德尔基金会的最新报告。
Immunol Res. 2011 Oct;51(1):61-70. doi: 10.1007/s12026-011-8241-y.
10
A multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparation.一项评估新型静脉用免疫球蛋白制剂 Intratect®的疗效和安全性的多中心研究。
Clin Exp Immunol. 2010 Sep;161(3):512-7. doi: 10.1111/j.1365-2249.2010.04187.x.
本文引用的文献
1
Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications.原发性低丙种球蛋白血症：临床表现及并发症调查
Q J Med. 1993 Jan;86(1):31-42.
2
X-linked immunodeficiency. The fruits of cooperation.X连锁免疫缺陷。合作的成果。
Nature. 1993 Feb 11;361(6412):494. doi: 10.1038/361494a0.
3
The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.与X连锁无丙种球蛋白血症相关的基因是蛋白质酪氨酸激酶src家族的成员。
Nature. 1993 Jan 21;361(6409):226-33. doi: 10.1038/361226a0.
4
Adverse effects of intravenous immunoglobulin.静脉注射免疫球蛋白的不良反应。
Drug Saf. 1993 Oct;9(4):254-62. doi: 10.2165/00002018-199309040-00003.
5
Primary hypogammaglobulinaemia: impaired lung function and body growth with delayed diagnosis and inadequate treatment.原发性低丙种球蛋白血症：肺功能和身体生长受损，诊断延迟且治疗不足。
Eur J Respir Dis. 1984 Oct;65(7):529-36.
6
Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA.低丙种球蛋白血症患者注射丙种球蛋白后的过敏反应。IgA特异性IgE抗体的检测。
N Engl J Med. 1986 Feb 27;314(9):560-4. doi: 10.1056/NEJM198602273140907.
7
Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies.抗体缺陷综合征和抗IgA抗体患者的免疫球蛋白预防治疗
J Clin Immunol. 1987 Jan;7(1):8-15. doi: 10.1007/BF00915419.
8
Immunoglobulin replacement therapy by self-infusion at home.在家自行输注免疫球蛋白替代疗法。
Clin Exp Immunol. 1988 Jul;73(1):160-2.
9
Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency.静脉注射免疫球蛋白预防措施导致77例低丙种球蛋白血症或IgG亚类缺陷患者中的16例出现肝损伤。
Am J Med. 1988 Jan;84(1):107-11. doi: 10.1016/0002-9343(88)90016-2.
10
Elimination of infectious retroviruses during preparation of immunoglobulins.
Transfusion. 1986 Jul-Aug;26(4):394-7. doi: 10.1046/j.1537-2995.1986.26486262753.x.
Zotero 插件